相关临床试验
0
0 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
N/A
暂无试验阶段数据
暂无试验数据
暂无试验数据
暂无批准数据
- India's drug regulator CDSCO revealed that 1,705 clinical trial participants died from serious adverse events between 2021 and July 2025, averaging one death per day. - An additional 7,189 non-fatal serious adverse events were recorded during the same period, affecting an average of 4.2 people daily with life-threatening side effects. - Only 68 families received compensation out of all 1,705 deaths, highlighting significant gaps in participant protection and accountability. - A recent case in Hyderabad exposed potential regulatory violations, including unregistered trials and inadequate medical care for participants experiencing adverse events.
• The U.S. healthcare contract research organization market is expected to grow from $15.01 billion in 2025 to $29.68 billion by 2034, driven by increasing R&D investments and technological advancements. • Artificial intelligence integration is revolutionizing CRO operations through enhanced clinical trial design, automated data management, and improved patient recruitment, significantly boosting efficiency and productivity. • The preclinical CRO segment is projected to reach $4.66 billion by 2034, with an 8.2% CAGR, as pharmaceutical companies increasingly outsource specialized research services to reduce costs and accelerate drug development.
